To highlight the current aspects and developments in the management of neurogenic urine
storage dysfunction and to sensitize urologists for this interdisciplinary and important topic …

Intra-detrusor injection therapy with onabotulinumtoxinA is generally accepted as a highly
effective, minimally invasive and well-tolerated day procedure for patients with refractory …

Dystonia and muscle spasms are a group of common and unfavorable clinical neurological
symptoms. The use of botulinum toxin (BTX‐A) abroad has achieved good results in the …

Background Transient increases in postvoid residual urine volume (PVR) requiring clean
intermittent catheterization (CIC) have occurred with onabotulinumtoxinA treatment for …

Objectives The objective of this study was to evaluate the risk of postprocedure urinary tract
infection (UTI) after injection of onabotulinum toxin A (BTX-A) in women who had a UTI …

Purpose: To investigate the clinical effect of combined use of botulinum toxin type A and
electromyographic biofeedback therapy (EMGBFT) on post-stroke patients with lower limb …

Изучали влияние дозы ботулинического токсина А первого типа (БТА) на
эффективность терапии у больных с нейрогенной (НДГ) и идиопатической (ИДГ) …

La inyección de toxina botulínica en el detrusor es un tratamiento validado, de segunda
línea, de la incontinencia urinaria por hiperactividad vesical en los pacientes no …

Objective We aimed to assess the variation in definitions of urinary retention across studies
of BTX for the treatment of OAB. Study Design We performed a systematic review of studies …

Background This pooled analysis of randomized controlled studies investigated the safety
and efficacy of onabotulinumtoxinA in male and female patients with overactive bladder …